A mutation in at least one of the five genes (TP53, PIK3CA, ERBB2, ESR1, AKT1) was identified in most cases, with 90.6% of primary BC and 87.5% of the paired BMs having at least one mutation. The gene discussed is ERBB2; the disease is breast cancer.